J.M. Fernández Gómez

Author

Hospital Universitario Central de Asturias ORCID

Also Known As

J Fernandez-Gomez, J Fernández, J Fernández Gómez, J Fernández-Gómez, J GOMEZ, J Gomez, J Gómez, J M FERNANDEZ, J M Fernandez, J M Fernandez Gomez

356

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Central de Asturias Universidad de Oviedo Puigvert Foundation Fundación Hospital de Jove Hospital de Basurto

About

J.M. Fernández Gómez is an author at Hospital Universitario Central de Asturias specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	28	1.5K
2	Health Sciences	1	1	30
3	Public Health	1	1	165
4	Allergy	1	1	34
5	Biomedical Engineering	1	1	30

J.M. Fernández Gómez

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model J.M. Fernández Gómez, Rosário Madero, Eduardo Solsona, The Journal of Urology	2009	639
Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials J.M. Fernández Gómez, Eduardo Solsona, Miguel Unda, European Urology Prognostic FactorsUrologyBacillus Calmette-guérinUrologic Cancer EpidemiologyGenitourinary Cancer	2007	254
Gut microbiota dysbiosis in a cohort of patients with psoriasis Claudio Hidalgo-Cantabrana, J.M. Fernández Gómez, Susana Delgado, British Journal of Dermatology	2019	224
A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C Antonio Ojea, José Luís Nogueira, Eduardo Solsona, European Urology UrologySurgical OncologyGenitourinary CancerMedicineVersus Mitomycin C	2007	204
The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables J.M. Fernández Gómez, Rosário Madero, Eduardo Solsona, European Urology External ValidationSurgical OncologyUrologyCancer EpidemiologyUrologic Cancer Epidemiology	2011	165
Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids Ana Suárez, Patricia López, J.M. Fernández Gómez, Annals of the Rheumatic Diseases	2006	145
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence Salomé González‐Reyes, J.M. Fernández Gómez, Luis O. González, Cancer Immunology Immunotherapy UrologyBiochemical RecurrenceGenitourinary CancerMedicinePathology	2010	130
Study of matrix metalloproteinases and their inhibitors in prostate cancer Safwan Escaff, J.M. Fernández Gómez, Luis O. González, British Journal of Cancer UrologyBasal MembraneExtracellular Matrix MetalloproteasesGenitourinary CancerMedicine	2010	91
Correlation between maximum cervical dilatation at cesarean delivery and subsequent vaginal birth after cesarean delivery I ABBASIHOSKINS, J.M. Fernández Gómez Obstetrics and Gynecology	1997	87
Oncological outcome following anastomotic leak in rectal surgery Eloy Espín, M. A. Ciga, Manuel Pera, British journal of surgery	2015	77

Page 1